The top 100 stock
market authors
selected for publication
market authors
selected for publication
Onyx Pharmaceuticals Inc. (ONXX) ()
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Onyx Pharmaceuticals Inc. (ONXX) by latest | most commented
- Pharmaceutical Dollar Rationing by Results
- Keryx: Another Beneficiary of the ASCO Effect
- Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
- Big Pharma's Pheeding Phrenzy
- Pequot Capital Closes: Expect Downward Pressure on Top Holdings
- Friday's Options Recap
- Pequot Capital: Yet Another Hedge Fund Buying Gold
- Arena's Financing Deal with Azimuth Is a Healthy Move
- Tudor Investment Takes New Positions in Financials, Among Others
- Where Might Genentech Investors Redeploy $47B?
- China Biopharma Undergoes Systemic Changes
- China Biotech Gets Off to a Slow Start for 2009
- Fast Money Recap - Bullish on Biotech (1/5/09)
- Hedge Fund Tracking: Pequot Capital Management (Art Samberg), Q3 2008
- What Are Some of the Best Hedge Fund Managers Doing?
- Onyx's $320M Bet on BTG's Anticancer Compound
- Even Fatter Yields for Pfizer; M&A Targets in the Sector
- U.K. Limits 'Quality of Life' Meds to £30,000 a Year
- 41 Stocks Returning 10% or More Last Week
- 5 Potential Buyout Targets in Biotech - Barron's
- A Biotech Bloom in July
- Delcath Systems to Take on Onyx Pharma's Nexavar
- Oncology Conference Countdown: What Will Pharma and Biotech Companies Report?
- Six Significant Gene Therapy Stocks
- Friday's Options Report: MCO, YRCW, TLM, IMA, ONXX
- Last Year's Best Stocks Have Been This Year's Worst
- Onyx's New CEO - What You Won't Find In PR
- Wednesday's Options Report: SLE, T, HPQ, CROX, KFN, BRCD, ONXX, KEY, XLF
- Onyx Pharma Should Bounce Following Lung Cancer Drug News
- Wall Street Breakfast: Must-Know News
- 2007 Biotech Performance Review
- 2007's Best, Worst Performers Faring Poorly in 2008
- Best Performing Stocks YTD
- Biotech Fund IBB May Ride the M&A Frenzy, but It's Still Wildly Volatile
- Best and Worst Performing U.S. Stocks YTD
- Onyx's Cancer Drug: Potential Blockbuster - But With Competition
- Best Performers YTD
- Best, Worst Performing Stocks of 2007
- Cancer Stocks Finish a Tough Quarter
- Best, Worst Performing Stocks of 2007
- Loeb's Third Point Issues Latest 13F: Summary of Holdings
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largest
increase in followers
in the last 7 days-
1
Philip Davis
-
2
David Fry
-
3
TraderMark
-
4
Bill Gross
-
5
Tyler Durden
Fastest Climbers » -
1
-
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
